Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking

Mehmet Şahinbaş1, İdris Buğra Çerik2, Duygu Yalınbaş Yeter3

  • 1Department of Cardiology, Sivas Numune Hospital, Sivas, Turkey.

Abstract

Insights

Intravitreal anti-VEGF agents may impact heart function. This study found a statistically significant decrease in global longitudinal strain (GLS) after three months of treatment, suggesting potential cardiac effects from these localized treatments.

Area of Science:

  • Cardiology
  • Ophthalmology
  • Pharmacology

Background:

  • Vascular endothelial growth factor (VEGF) inhibitors are used systemically in oncology and ophthalmology.
  • Systemic anti-VEGF use is linked to cardiovascular risks, but local application effects are unknown.
  • Investigating cardiac effects of intravitreal anti-VEGF is crucial.

Purpose of the Study:

  • To evaluate the impact of intravitreal anti-VEGF agents on left heart function.
  • To assess changes in cardiac mechanics using speckle tracking echocardiography.
  • To determine if local anti-VEGF therapy affects cardiac performance.

Main Methods:

  • Prospective study including 44 patients undergoing intravitreal anti-VEGF treatment.
  • Speckle tracking echocardiography performed before treatment and at three months.
  • Analysis of global longitudinal strain (GLS) and regional GLS values.

Main Results:

  • A statistically significant decrease in global longitudinal strain (GLS) was observed at three months.
  • Significant reductions in GLS were noted in apical four-chamber, apical long-axis, and apical two-chamber views.
  • Mean GLS values decreased significantly from baseline to three months post-treatment.

Conclusions:

  • Intravitreal anti-VEGF agents may induce subtle cardiac effects.
  • A slight decrease in GLS suggests potential cardiac alterations after local anti-VEGF therapy.
  • Further research is warranted to understand the clinical significance of these findings.